Persistent Lyme Disease Symptoms After Treatment

Persistent Lyme disease symptoms may continue after standard treatment
Fatigue, pain, and cognitive problems may significantly affect quality of life
Delayed diagnosis, neurologic involvement, and coinfections may complicate recovery

The Infectious Disease Society of America (IDSA) published evidence-based treatment guidelines in 2006 which states, “Considerable confusion and controversy exist over the frequency and cause of this process [chronic Lyme disease] and even over its existence.” Furthermore, any “[ongoing] symptoms appear to be more related to the aches and pains of daily living rather than to either Lyme disease or a tick-borne co-infection.” [1]

However, a growing number of studies are reporting treatment failures among patients whose symptoms comprise more than the aches and pains of daily living and describe significant long-term consequences of Lyme disease.

According to a case series published in the New England Journal of Medicine, Lyme disease patients were ill up to 14 years with Lyme encephalopathy and Lyme neuropathy despite antibiotic therapy.

Persistent symptoms may include fatigue, widespread pain, exercise intolerance, cognitive impairment, dizziness, headaches, sleep disruption, and neurologic complaints that interfere with daily functioning.

These symptoms are often discussed within the framework of post-treatment Lyme disease syndrome and may overlap with broader discussions surrounding persistent Lyme disease.

There are other studies reporting treatment failure and complications after antibiotic therapy:

• 34% of a population-based, retrospective cohort were ill an average of 6.2 years after antibiotic treatment [2];
• 62% of a retrospective evaluation of 215 Lyme disease patients from Westchester County, NY, remained ill an average of 3.2 years after antibiotic treatment [3];
• 57% of 30 adults with Lyme Neuroborreliosis remained ill years after treatment at the Medical Center, University of Freiburg. [4] Read the details in another article on Lyme neuroborreliosis outcomes;
• A meta-analysis of 504 patients treated for Lyme disease found this group had more fatigue, musculoskeletal pain and neurocognitive difficulties than 530 controls. [5] Additionally, it demonstrated that persistent Lyme disease symptoms were a distinct set of symptoms, which differed from those of fibromyalgia, chronic fatigue syndrome and depression; [5]

Meanwhile, four clinical trials sponsored by the National Institutes of Health (NIH) validated the potential seriousness of Lyme disease. [6-8]

The trials demonstrated that the patients’ quality of life was consistently worse than that of control populations and “was equivalent to that of patients with congestive heart failure; pain levels were similar to those of post-surgical patients and fatigue was on par with that seen in multiple sclerosis,” according to the International Lyme and Associated Diseases Society’s (ILADS) 2014 evidence-based guidelines. [9]

Patients with neurologic Lyme disease may be particularly vulnerable to long-term cognitive impairment, fatigue, sensory symptoms, and reduced quality of life.

In an effort to help identify those patients who fail the IDSA’s recommended course of treatment, the medical society proposed a case definition for post–Lyme disease syndrome.

“In an attempt to provide a framework for future research on this subject and to reduce diagnostic ambiguity in study populations, a definition for post–Lyme disease is proposed.” [1]

The proposed definition of post–Lyme disease syndrome (PTLDS) includes the following:

1. A documented episode of early or late Lyme disease;
2. Resolution or stabilization of the objective manifestation(s) of Lyme disease after treatment of the episode of Lyme disease with a generally accepted treatment regimen;
3. Onset of any of the fatigue, widespread musculoskeletal pain, and/or complaints of cognitive difficulties within 6 months of the diagnosis of Lyme disease and persistence of continuous or relapsing of these symptoms for at least a 6-month period after completion of antibiotic therapy;
4. Subjective symptoms are of such severity that, when present, result in substantial reduction in previous levels of occupational, educational, social, or personal activities. [1]

Researchers at Johns Hopkins University School of Medicine examined the incidence and severity of post-Lyme disease syndrome in Lyme disease patients who were treated early – at the time of an erythema migrans (EM) rash – with a 3-week course of doxycycline.

The study confirmed the high incidence and severity of post-Lyme disease despite a 3-week course of doxycycline. [10]

“At six months, 36% of patients reported new-onset fatigue, 20% widespread pain, and 45% neurocognitive difficulties,” according to Aucott, lead author of the study.

“Patients who developed PTLDS had significantly lower life functioning compared to those without PTLDS.” [10]

“Six Lyme disease patients (10%) were subsequently re-treated for primary treatment failures, including 3 with new neurologic abnormalities documented on nerve conduction studies and 3 whose primary EM rash enlarged during antibiotic treatment,” Aucott points out.

Meanwhile, Krause stressed the importance of considering Lyme coinfections when treating patients, pointing out, “epidemiologic studies have documented that up to 40% of patients with Lyme disease experience concurrent Babesiosis.” [11]

The NIH trials demonstrated differences in outcomes for individuals treated early versus those treated later in the disease course.

Patients who enrolled in the Klempner trials had been ill an average of 4.7 years. [12] The Fallon trials enrolled patients who had been sick for an average of 9 years. [7]

These findings reinforce concerns that delayed Lyme disease diagnosis may contribute to more complicated recovery trajectories for some patients.

The uniform message to Lyme disease patients has often been that it is “easy to treat” and “quick to fix.” However, the medical literature demonstrates that outcomes vary considerably from patient to patient.

An increasing number of physicians recognize that a one-size-fits-all approach is not always successful in restoring a patient’s health.

Additional discussions surrounding persistent Lyme disease symptoms after treatment continue to explore why some patients experience prolonged fatigue, pain, neurologic symptoms, and impaired quality of life despite standard therapy.

Frequently Asked Questions

Can Lyme disease symptoms continue after antibiotics?

Yes. Some patients report persistent fatigue, pain, cognitive problems, and neurologic symptoms despite standard antibiotic treatment.

What is post-treatment Lyme disease syndrome?

Post-treatment Lyme disease syndrome (PTLDS) refers to persistent symptoms that continue for months after completion of recommended Lyme disease therapy.

Why do some Lyme disease patients remain ill?

Researchers continue to investigate multiple factors including delayed diagnosis, immune dysregulation, neurologic involvement, inflammation, and coinfections.

Can coinfections complicate Lyme disease recovery?

Yes. Babesia and other tick-borne coinfections may contribute to persistent symptoms and more complicated clinical presentations.

Can patients recover from persistent Lyme disease symptoms?

Recovery varies widely. Some patients improve steadily while others experience prolonged or relapsing symptoms requiring individualized management.

Clinical Takeaway

Persistent Lyme disease symptoms after treatment remain an important clinical challenge for patients and physicians alike.

Studies have documented long-term fatigue, pain, neurocognitive symptoms, and impaired quality of life in subsets of patients despite standard antibiotic therapy.

Careful evaluation of delayed diagnosis, neurologic involvement, coinfections, and individualized recovery patterns may help guide a more comprehensive clinical approach.

Related Articles

These related articles explore persistent symptoms, delayed diagnosis, autonomic dysfunction, recovery challenges, and symptom patterns associated with Lyme disease.

Delayed Lyme disease diagnosis
Lyme disease misdiagnosis
Autonomic dysfunction in Lyme disease
Recovery from Lyme disease
Lyme disease symptoms guide

References

1. 1. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
   2. Shadick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease: a population-based retrospective cohort study. Ann Intern Med. 1994;121(8):560-567.
   3. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol. 1994;21(3):454-461.
   4. Dersch R, Sarnes AA, Maul M, et al. Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol. 2015.
   5. Cairns V, Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol. 2005;34(6):1340-1345.
   6. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345(2):85-92.
   7. Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003.
   8. Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60(12):1923-1930.
   9. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014.
   10. Aucott JN, Rebman AW, Crowder LA, Kortte KB. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res. 2013;22(1):75-84.
   11. Diuk-Wasser MA, Vannier E, Krause PJ. Coinfection by Ixodes tick-borne pathogens: ecological, epidemiological, and clinical consequences. Trends Parasitol. 2015.
   12. Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis. 2002;2(4):255-263.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention